NASDAQ:BLTE

Belite Bio Stock Forecast

etoro logo Buy BLTE
*Your capital is at risk
$163.05
+2.38 (+1.48%)
At Close: Aug 07, 2026

Should you buy BLTE stock?

Last updated:

Based on market data through , StockInvest.us rates Belite Bio, Inc (BLTE) as a Strong Buy Candidate with a technical score of 7.88 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 1.96%
  • 3-month trend forecast Up 9.85%
  • Strong Buy Candidate 7.88
AI Analysis AI Analysis of BLTE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BLTE to Watchlist?
Some Reasons Why To Add BLTE:
  • Lower volatility than the market (beta -1.23)
  • +133.3% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 249.94)
PDF

Belite Bio, Inc stock upgraded from Buy Candidate to Strong Buy Candidate after Friday trading session
(Market data through Aug 07, 2026)

Buy or Hold candidate since Jul 30, 2026 Gain 1.96%

The Belite Bio, Inc stock price gained 1.48% on the last trading day (Friday, 7th Aug 2026), rising from $160.67 to $163.05. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.63% from a day low at $161.67 to a day high of $164.30. The price has risen in 6 of the last 10 days and is up by 6.32% over the past 2 weeks. Volume fell on the last day by -7 thousand shares and in total, 126 thousand shares were bought and sold for approximately $20.62 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.85% during the next 3 months and, with a 90% probability hold a price between $160.66 and $187.09 at the end of this 3-month period.

BLTE Signals & Forecast

Mostly positive signals in the chart today. The Belite Bio, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $158.97 and $153.03. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 20.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Belite Bio, Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $147.00 and $144.18. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Belite Bio, Inc finds support just below today's level at $147.00. If this is broken, then the next support from accumulated volume will be at $144.18 and $134.93.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.63 between high and low, or 1.63%. For the last week, the stock has had daily average volatility of 2.61%.

Our recommended stop-loss: $157.70 (-3.28%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 46 days ago.)

Trading Expectations (BLTE) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Belite Bio, Inc to open at $163.01, and during the day (based on 14 day Average True Range), to move between $160.04 and $166.06, which gives a possible trading interval of +/-$6.02 (+/-3.76%) up or down from last closing price. If Belite Bio, Inc takes out the full calculated possible swing range there will be an estimated 3.76% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $147.00, some $16.05 (9.84%) from the current price of $163.05, our system finds the risk reward attractive.

Earnings coming up

Belite Bio, Inc will release earnings AMC on Wednesday, August 12, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.663. We will update the financials statements for Belite Bio, Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.86% in the first trading day after earnings release.

Is Belite Bio, Inc stock A Buy?

Belite Bio, Inc holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 7.880 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $163.01 ( 0.0266%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BLTE Performance

Trading levels for BLTE

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 165.64 1.59%
R2 164.63 0.97%
R1 164.01 0.590%
Price 163.05
S1 162.00 -0.643%
S2 161.38 -1.02%
S3 160.38 -1.64%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 163.05
S1 147.00 -9.84%
S2 144.18 -11.57%
S3 134.93 -17.25%

FAQ

What is the symbol for Belite Bio, Inc Stock and on which exchange is it traded?
The symbol for Belite Bio, Inc is BLTE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Belite Bio, Inc Stock?
Based on market data through Aug 07, 2026, StockInvest.us rates Belite Bio, Inc (BLTE) as a Strong Buy Candidate with a technical score of 7.88 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation. Since the Buy signal began on Jul 30, 2026, the price has risen 1.96%. The current 3-month trend forecast projects a rise of 9.85%.

How to buy Belite Bio, Inc Stock?
Belite Bio, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Belite Bio, Inc Stock.

What's the current price of Belite Bio, Inc Stock?
As of the end of day on the Aug 07, 2026, the price of an Belite Bio, Inc (BLTE) share was $163.05.

What is the 52-week high and low for Belite Bio, Inc Stock?
The 52-week high for Belite Bio, Inc Stock is $199.85 and the 52-week low is $60.00.

What is the market capitalization of Belite Bio, Inc Stock?
As of the Aug 07, 2026, the market capitalization of Belite Bio, Inc is 6.536B.

When is the next earnings date for Belite Bio, Inc?
The upcoming earnings date for Belite Bio, Inc is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT BELITE BIO, INC
Belite Bio
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that ...
GOLDEN STAR
Ticker Change Signal Date
MHO
$150.54
0.96% Aug 05
JEF
$55.71
1.63% Aug 04
FCX
$62.63
11.16% Jul 31
BIIB
$202.19
2.84% Jul 24
S
SW
$43.71
10.46% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE